184 related articles for article (PubMed ID: 10436957)
21. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
[TBL] [Abstract][Full Text] [Related]
22. Serum concentrations of tumour necrosis factor-alpha (TNF-alpha) and soluble TNF-alpha receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function.
Díez JJ; Hernanz A; Medina S; Bayón C; Iglesias P
Clin Endocrinol (Oxf); 2002 Oct; 57(4):515-21. PubMed ID: 12354134
[TBL] [Abstract][Full Text] [Related]
23. IgA triggers tumor necrosis factor alpha secretion by monocytes: a study in normal subjects and patients with alcoholic cirrhosis.
Devière J; Vaerman JP; Content J; Denys C; Schandene L; Vandenbussche P; Sibille Y; Dupont E
Hepatology; 1991 Apr; 13(4):670-5. PubMed ID: 2010162
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor (TNF)alpha and its soluble receptor (sTNFR) p75 during acute human parvovirus B19 infection in children.
Barash J; Dushnitzki D; Barak Y; Miron S; Hahn T
Immunol Lett; 2003 Aug; 88(2):109-12. PubMed ID: 12880679
[TBL] [Abstract][Full Text] [Related]
25. Intracellular monocyte cytokine production and CD 14 expression are up-regulated in severe vs mild chronic heart failure.
Conraads VM; Bosmans JM; Schuerwegh AJ; Goovaerts I; De Clerck LS; Stevens WJ; Bridts CH; Vrints CJ
J Heart Lung Transplant; 2005 Jul; 24(7):854-9. PubMed ID: 15982613
[TBL] [Abstract][Full Text] [Related]
26. Circadian fluctuations of melatonin, tumor necrosis factor-alpha and its soluble receptors in the circulation of patients with advanced gastrointestinal cancer.
Muc-Wierzgon M; Nowakowska-Zajdel E; Zubelewicz B; Wierzgon J; Kokot T; Klakla K; Szkilnik R; Wiczkowski A
J Exp Clin Cancer Res; 2003 Jun; 22(2):171-8. PubMed ID: 12866566
[TBL] [Abstract][Full Text] [Related]
27. Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake.
Laso FJ; Lapeña P; Madruga JI; San Miguel JF; Orfao A; Iglesias MC; Alvarez-Mon M
Alcohol Clin Exp Res; 1997 Oct; 21(7):1226-31. PubMed ID: 9347083
[TBL] [Abstract][Full Text] [Related]
28. Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-kappaB activity and TNF expression: relevance to alcoholic liver disease.
Gobejishvili L; Barve S; Joshi-Barve S; Uriarte S; Song Z; McClain C
Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G681-8. PubMed ID: 16751174
[TBL] [Abstract][Full Text] [Related]
29. Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis.
Zhao J; Zhao S; Zhou G; Liang L; Guo X; Mao P; Zhou X; Wang H; Nan Y; Xu D; Yu J
Scand J Gastroenterol; 2011 Apr; 46(4):485-94. PubMed ID: 21275501
[TBL] [Abstract][Full Text] [Related]
30. Polymorphonuclear granulocytes enhance lipopolysaccharide-induced soluble p75 tumor necrosis factor receptor release from mononuclear cells.
Lien E; Liabakk NB; Johnsen AC; Nonstad U; Sundan A; Espevik T
Eur J Immunol; 1995 Sep; 25(9):2714-7. PubMed ID: 7589151
[TBL] [Abstract][Full Text] [Related]
31. Proinflammatory cytokine inhibitors, TNF-alpha and oxidative burst of polymorphonuclear leukocytes in the pathogenesis of sepsis in newborns.
Sikora JP; Chlebna-Sokół D; Dabrowska I; Lipczyński D; Chrul S
Arch Immunol Ther Exp (Warsz); 2001; 49(2):155-61. PubMed ID: 11348020
[TBL] [Abstract][Full Text] [Related]
32. Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-alpha.
Comini L; Bachetti T; Agnoletti L; Gaia G; Curello S; Milanesi B; Volterrani M; Parrinello G; Ceconi C; Giordano A; Corti A; Ferrari R
Eur Heart J; 1999 Oct; 20(20):1503-13. PubMed ID: 10493849
[TBL] [Abstract][Full Text] [Related]
33. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
[TBL] [Abstract][Full Text] [Related]
34. Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity.
Naveau S; Emilie D; Balian A; Grangeot-Keros L; Borotto E; Portier A; Giraud V; Capron F; Galanaud P; Chaput JC
J Hepatol; 1998 May; 28(5):778-84. PubMed ID: 9625312
[TBL] [Abstract][Full Text] [Related]
35. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia.
Visser W; Beckmann I; Knook MA; Wallenburg HC
Acta Obstet Gynecol Scand; 2002 Aug; 81(8):713-9. PubMed ID: 12174154
[TBL] [Abstract][Full Text] [Related]
36. LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma.
Bemelmans MH; Gouma DJ; Buurman WA
J Immunol; 1993 Nov; 151(10):5554-62. PubMed ID: 8228246
[TBL] [Abstract][Full Text] [Related]
37. Ibuprofen does not affect levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptor types I and II in Gabonese children with uncomplicated Plasmodium falciparum malaria.
Matsiegui PB; Missinou MA; Issifou S; Necek M; Mavoungou E
Eur Cytokine Netw; 2007 Dec; 18(4):201-5. PubMed ID: 17964975
[TBL] [Abstract][Full Text] [Related]
38. High serum TNF-alpha level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells.
Makino N; Maeda T; Sugano M; Satoh S; Watanabe R; Abe N
J Diabetes Complications; 2005; 19(6):347-55. PubMed ID: 16260352
[TBL] [Abstract][Full Text] [Related]
39. Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt.
Trebicka J; Krag A; Gansweid S; Appenrodt B; Schiedermaier P; Sauerbruch T; Spengler U
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1218-25. PubMed ID: 21971377
[TBL] [Abstract][Full Text] [Related]
40. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.
Rogy MA; Coyle SM; Oldenburg HS; Rock CS; Barie PS; Van Zee KJ; Smith CG; Moldawer LL; Lowry SF
J Am Coll Surg; 1994 Feb; 178(2):132-8. PubMed ID: 8173722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
